InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Shulman Joseph, Chief Technical Officer. Officer active across 1 companies, notably Rhythm Pharmaceuticals, INC.. In total, 3 disclosures have been recorded. The latest transaction was filed on 28 October 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
US$49,1522,094 shares@ US$23.4729100.0% of flow
Common Stock
SEC:0001104659-25-104437·
€49,1522,094 shares@ €23.47290.0008% mcap50.0% of flow
Common Stock
SEC:0001104659-25-104437:0·
1,563 shares
Common Stock
SEC:0001104659-22-023952:0·
3 of 3 declarations
About Shulman Joseph
Shulman Joseph is the Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC. He is responsible for the technical strategy and product development of the company. His role is essential in ensuring that RHYTHM's innovations meet market needs and safety standards.
